554 related articles for article (PubMed ID: 28404863)
21. A Novel Splice-Acceptor Site Mutation in GRN (c.709-2 A>T) Causes Frontotemporal Dementia Spectrum in a Large Family from Southern Italy.
Sassi C; Capozzo R; Gibbs R; Crews C; Zecca C; Arcuti S; Copetti M; Barulli MR; Brescia V; Singleton AB; Logroscino G
J Alzheimers Dis; 2016 May; 53(2):475-85. PubMed ID: 27258413
[TBL] [Abstract][Full Text] [Related]
22. Rare variants in the neuronal ceroid lipofuscinosis gene MFSD8 are candidate risk factors for frontotemporal dementia.
Geier EG; Bourdenx M; Storm NJ; Cochran JN; Sirkis DW; Hwang JH; Bonham LW; Ramos EM; Diaz A; Van Berlo V; Dokuru D; Nana AL; Karydas A; Balestra ME; Huang Y; Russo SP; Spina S; Grinberg LT; Seeley WW; Myers RM; Miller BL; Coppola G; Lee SE; Cuervo AM; Yokoyama JS
Acta Neuropathol; 2019 Jan; 137(1):71-88. PubMed ID: 30382371
[TBL] [Abstract][Full Text] [Related]
23. The lysosomal function of progranulin, a guardian against neurodegeneration.
Paushter DH; Du H; Feng T; Hu F
Acta Neuropathol; 2018 Jul; 136(1):1-17. PubMed ID: 29744576
[TBL] [Abstract][Full Text] [Related]
24. A systematic review of progranulin concentrations in biofluids in over 7,000 people-assessing the pathogenicity of GRN mutations and other influencing factors.
Swift IJ; Rademakers R; Finch N; Baker M; Ghidoni R; Benussi L; Binetti G; Rossi G; Synofzik M; Wilke C; Mengel D; Graff C; Takada LT; Sánchez-Valle R; Antonell A; Galimberti D; Fenoglio C; Serpente M; Arcaro M; Schreiber S; Vielhaber S; Arndt P; Santana I; Almeida MR; Moreno F; Barandiaran M; Gabilondo A; Stubert J; Gómez-Tortosa E; Agüero P; Sainz MJ; Gohda T; Murakoshi M; Kamei N; Kittel-Schneider S; Reif A; Weigl J; Jian J; Liu C; Serrero G; Greither T; Theil G; Lohmann E; Gazzina S; Bagnoli S; Coppola G; Bruni A; Quante M; Kiess W; Hiemisch A; Jurkutat A; Block MS; Carlson AM; Bråthen G; Sando SB; Grøntvedt GR; Lauridsen C; Heslegrave A; Heller C; Abel E; Gómez-Núñez A; Puey R; Arighi A; Rotondo E; Jiskoot LC; Meeter LHH; Durães J; Lima M; Tábuas-Pereira M; Lemos J; Boeve B; Petersen RC; Dickson DW; Graff-Radford NR; LeBer I; Sellami L; Lamari F; Clot F; Borroni B; Cantoni V; Rivolta J; Lleó A; Fortea J; Alcolea D; Illán-Gala I; Andres-Cerezo L; Van Damme P; Clarimon J; Steinacker P; Feneberg E; Otto M; van der Ende EL; van Swieten JC; Seelaar H; Zetterberg H; Sogorb-Esteve A; Rohrer JD
Alzheimers Res Ther; 2024 Mar; 16(1):66. PubMed ID: 38539243
[TBL] [Abstract][Full Text] [Related]
25. Reduction of microglial progranulin does not exacerbate pathology or behavioral deficits in neuronal progranulin-insufficient mice.
Arrant AE; Filiano AJ; Patel AR; Hoffmann MQ; Boyle NR; Kashyap SN; Onyilo VC; Young AH; Roberson ED
Neurobiol Dis; 2019 Apr; 124():152-162. PubMed ID: 30448285
[TBL] [Abstract][Full Text] [Related]
26. Selectivity and Kinetic Requirements of HDAC Inhibitors as Progranulin Enhancers for Treating Frontotemporal Dementia.
She A; Kurtser I; Reis SA; Hennig K; Lai J; Lang A; Zhao WN; Mazitschek R; Dickerson BC; Herz J; Haggarty SJ
Cell Chem Biol; 2017 Jul; 24(7):892-906.e5. PubMed ID: 28712747
[TBL] [Abstract][Full Text] [Related]
27. Accelerated lipofuscinosis and ubiquitination in granulin knockout mice suggest a role for progranulin in successful aging.
Ahmed Z; Sheng H; Xu YF; Lin WL; Innes AE; Gass J; Yu X; Wuertzer CA; Hou H; Chiba S; Yamanouchi K; Leissring M; Petrucelli L; Nishihara M; Hutton ML; McGowan E; Dickson DW; Lewis J
Am J Pathol; 2010 Jul; 177(1):311-24. PubMed ID: 20522652
[TBL] [Abstract][Full Text] [Related]
28. Progranulin deficiency results in sex-dependent alterations in microglia in response to demyelination.
Zhang T; Feng T; Wu K; Guo J; Nana AL; Yang G; Seeley WW; Hu F
Acta Neuropathol; 2023 Jul; 146(1):97-119. PubMed ID: 37120788
[TBL] [Abstract][Full Text] [Related]
29. Possible involvement of lysosomal dysfunction in pathological changes of the brain in aged progranulin-deficient mice.
Tanaka Y; Chambers JK; Matsuwaki T; Yamanouchi K; Nishihara M
Acta Neuropathol Commun; 2014 Jul; 2():78. PubMed ID: 25022663
[TBL] [Abstract][Full Text] [Related]
30. Increased lysosomal biogenesis in activated microglia and exacerbated neuronal damage after traumatic brain injury in progranulin-deficient mice.
Tanaka Y; Matsuwaki T; Yamanouchi K; Nishihara M
Neuroscience; 2013 Oct; 250():8-19. PubMed ID: 23830905
[TBL] [Abstract][Full Text] [Related]
31. Induced pluripotent stem cell models of progranulin-deficient frontotemporal dementia uncover specific reversible neuronal defects.
Almeida S; Zhang Z; Coppola G; Mao W; Futai K; Karydas A; Geschwind MD; Tartaglia MC; Gao F; Gianni D; Sena-Esteves M; Geschwind DH; Miller BL; Farese RV; Gao FB
Cell Rep; 2012 Oct; 2(4):789-98. PubMed ID: 23063362
[TBL] [Abstract][Full Text] [Related]
32. Progranulin as a therapeutic target for dementia.
Galimberti D; Fenoglio C; Scarpini E
Expert Opin Ther Targets; 2018 Jul; 22(7):579-585. PubMed ID: 29889573
[TBL] [Abstract][Full Text] [Related]
33. Lysosomal processing of progranulin.
Zhou X; Paushter DH; Feng T; Sun L; Reinheckel T; Hu F
Mol Neurodegener; 2017 Aug; 12(1):62. PubMed ID: 28835281
[TBL] [Abstract][Full Text] [Related]
34. Progranulin: a proteolytically processed protein at the crossroads of inflammation and neurodegeneration.
Cenik B; Sephton CF; Kutluk Cenik B; Herz J; Yu G
J Biol Chem; 2012 Sep; 287(39):32298-306. PubMed ID: 22859297
[TBL] [Abstract][Full Text] [Related]
35. Plasma lysosphingolipids in GRN-related diseases: Monitoring lysosomal dysfunction to track disease progression.
Khrouf W; Saracino D; Rucheton B; Houot M; Clot F; Rinaldi D; Vitor J; Huynh M; Heng E; Schlemmer D; Pasquier F; Deramecourt V; Auriacombe S; Azuar C; Levy R; Bombois S; Boutoleau-Brétonnière C; Pariente J; Didic M; Wallon D; Fluchère F; Auvin S; Younes IB; ; ; Nadjar Y; Brice A; Dubois B; Bonnefont-Rousselot D; Le Ber I; Lamari F
Neurobiol Dis; 2023 Jun; 181():106108. PubMed ID: 37003407
[TBL] [Abstract][Full Text] [Related]
36. Preclinical Interventions in Mouse Models of Frontotemporal Dementia Due to Progranulin Mutations.
Kashyap SN; Boyle NR; Roberson ED
Neurotherapeutics; 2023 Jan; 20(1):140-153. PubMed ID: 36781744
[TBL] [Abstract][Full Text] [Related]
37. GRN-/- iPSC-derived cortical neurons recapitulate the pathological findings of both frontotemporal lobar degeneration and neuronal ceroidolipofuscinosis.
Bossolasco P; Cimini S; Maderna E; Bardelli D; Canafoglia L; Cavallaro T; Ricci M; Silani V; Marucci G; Rossi G
Neurobiol Dis; 2022 Dec; 175():105891. PubMed ID: 36220610
[TBL] [Abstract][Full Text] [Related]
38. Microglial NFκB-TNFα hyperactivation induces obsessive-compulsive behavior in mouse models of progranulin-deficient frontotemporal dementia.
Krabbe G; Minami SS; Etchegaray JI; Taneja P; Djukic B; Davalos D; Le D; Lo I; Zhan L; Reichert MC; Sayed F; Merlini M; Ward ME; Perry DC; Lee SE; Sias A; Parkhurst CN; Gan WB; Akassoglou K; Miller BL; Farese RV; Gan L
Proc Natl Acad Sci U S A; 2017 May; 114(19):5029-5034. PubMed ID: 28438992
[TBL] [Abstract][Full Text] [Related]
39. Multi-modal proteomic characterization of lysosomal function and proteostasis in progranulin-deficient neurons.
Hasan S; Fernandopulle MS; Humble SW; Frankenfield AM; Li H; Prestil R; Johnson KR; Ryan BJ; Wade-Martins R; Ward ME; Hao L
Mol Neurodegener; 2023 Nov; 18(1):87. PubMed ID: 37974165
[TBL] [Abstract][Full Text] [Related]
40. Progranulin regulates lysosomal function and biogenesis through acidification of lysosomes.
Tanaka Y; Suzuki G; Matsuwaki T; Hosokawa M; Serrano G; Beach TG; Yamanouchi K; Hasegawa M; Nishihara M
Hum Mol Genet; 2017 Mar; 26(5):969-988. PubMed ID: 28073925
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
